SCHATZMAN; RANDALL C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHATZMAN; RANDALL C..The latest application filed is for "antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever".

Company Profile

3.12.12

SCHATZMAN; RANDALL C. - REDMOND WA
Schatzman; Randall C. - Daly City CA
Schatzman, Randall C. - Shoreline WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antagonists Of Il-6 To Prevent Or Treat Cachexia, Weakness, Fatigue, And/or Fever App 20210107975 - SMITH; JEFFREY T.L. ; et al.	2021-04-15
Antagonists Of Il-6 To Prevent Or Treat Cachexia, Weakness, Fatigue, And/or Fever App 20190270805 - SMITH; JEFFREY T.L. ; et al.	2019-09-05
Antibodies To Il-6 And Use Thereof App 20190083665 - Garcia-Martinez; Leon F. ; et al.	2019-03-21
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Grant 10,160,804 - Smith , et al. Dec	2018-12-25
Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies Grant 10,117,955 - Garcia-Martinez , et al. November 6, 2	2018-11-06
Antagonists Of Il-6 To Prevent Or Treat Cachexia, Weakness, Fatigue, And/or Fever App 20170198036 - SMITH; Jeffrey T.L. ; et al.	2017-07-13
Antibodies To Il-6 And Use Thereof App 20170115307 - Garcia-Martinez; Leon ; et al.	2017-04-27
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Grant 9,546,213 - Smith , et al. January 17, 2	2017-01-17
Antagonists Of Il-6 To Prevent Or Treat Cachexia, Weakness, Fatigue, And/or Fever App 20110217303 - Smith; Jeffrey T.L. ; et al.	2011-09-08
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Grant 7,906,117 - Smith , et al. March 15, 2	2011-03-15
Antagonists of IL-6 to prevent or treat Cachexia, weakness, fatigue, and/or fever App 20090291077 - Smith; Jeffrey T.L. ; et al.	2009-11-26
Methods and compositions for diagnosis and treatment of iron misregulation diseases Grant 7,374,765 - Feder , et al. May 20, 2	2008-05-20
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases Grant 7,374,892 - Feder , et al. May 20, 2	2008-05-20
Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases Grant 7,329,650 - Feder , et al. February 12, 2	2008-02-12
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases Grant 7,119,170 - Feder , et al. October 10, 2	2006-10-10
Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases App 20050282754 - Feder, John N. ; et al.	2005-12-22
Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases Grant 6,924,265 - Feder , et al. August 2, 2	2005-08-02
Methods and compositions for diagnosis and treatment of iron misregulation diseases App 20050090430 - Feder, John N. ; et al.	2005-04-28
Methods and compositions for diagnosis and treatment of iron misregulation diseases Grant 6,849,399 - Feder , et al. February 1, 2	2005-02-01
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases App 20030073627 - Feder, John N. ; et al.	2003-04-17
Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases App 20020165162 - Feder, John N. ; et al.	2002-11-07
Novel matrix metalloproteinase (MMP-25) expressed in skin cells App 20020037827 - Wang, Kai ; et al.	2002-03-28
Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases Grant 6,284,732 - Feder , et al. September 4, 2	2001-09-04

Company Registrations

SEC

0001604763

Schatzman Randall C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.